CANTEL MEDICAL CORP - COM (CMD) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q2 2021

Type / Class: Equity / COM
Symbol: CMD

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Institutional Holders of CANTEL MEDICAL CORP - COM (CMD) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2021 Q2	0	$0	-$3,061,239,563	$0	$0		0
2021 Q1	38,343,239	$3,061,975,208	-$120,732,380	$3,033,000	$734,000	$79.84	227
2020 Q4	40,177,328	$3,168,623,223	+$13,977,552	$9,645,000	$3,186,000	$78.86	219
2020 Q3	40,803,582	$1,794,475,834	-$51,221,243	$6,112,000	$5,444,000	$43.94	188
2020 Q2	42,127,953	$1,863,528,265	+$59,550,482	$3,074,000	$4,032,000	$44.23	201
2020 Q1	40,811,783	$1,465,076,237	-$127,357,097	$1,819,000	$986,000	$35.90	200
2019 Q4	42,795,047	$3,033,819,410	+$177,551,741	$6,658,000	$4,162,000	$70.90	232
2019 Q3	40,305,964	$3,014,383,552	+$79,080,912	$5,748,000	$5,573,000	$74.80	239
2019 Q2	39,205,892	$3,161,175,854	+$214,185,579	$2,177,000	$5,523,000	$80.64	237
2019 Q1	36,883,298	$2,467,281,180	+$61,864,378	$1,472,000	$2,268,000	$66.89	245
2018 Q4	35,861,515	$2,670,063,873	-$48,294,193	$298,000	$1,266,000	$74.45	245
2018 Q3	36,272,923	$3,338,874,689	+$90,498,464	$6,159,000	$4,703,000	$92.06	281
2018 Q2	35,010,344	$3,443,489,574	+$13,605,292	$5,971,000	$8,457,000	$98.36	290
2018 Q1	34,609,394	$3,856,152,229	-$88,216,991	$3,075,000	$2,028,000	$111.41	270
2017 Q4	35,544,111	$3,656,697,618	-$76,422,704	$1,666,000	$5,174,000	$102.87	243
2017 Q3	36,283,617	$3,417,198,744	+$69,210,917	$10,868,000	$3,418,000	$94.17	229
2017 Q2	35,584,192	$2,772,260,337	+$52,369,601	$1,245,000	$1,521,000	$77.91	213
2017 Q1	35,258,994	$2,823,962,906	+$381,124,848	$1,959,000	$1,073,000	$80.10	218
2016 Q4	35,064,820	$2,761,330,566	+$4,289,964	$1,417,000	$1,307,000	$78.75	232
2016 Q3	35,005,784	$2,727,801,598	+$41,249,261	$1,354,000	$894,000	$77.98	224
2016 Q2	34,560,842	$2,374,445,428	-$31,087,306		$2,000	$68.73	226
2016 Q1	34,831,933	$2,485,416,641	+$23,101,544	$0	$0	$71.36	215
2015 Q4	34,542,902	$2,146,445,498	-$18,963,961	$155,000	$2,107,000	$62.14	196
2015 Q3	34,389,649	$1,949,790,294	+$24,010,670			$56.70	170
2015 Q2	34,536,152	$1,853,523,861	+$13,151,890			$53.67	160
2015 Q1	33,857,353	$1,607,763,400	+$16,574,374			$47.50	166
2014 Q4	34,001,636	$1,470,805,441	+$40,938,488			$43.26	165
2014 Q3	33,670,015	$1,157,580,118	+$6,261,679			$34.38	155
2014 Q2	33,460,302	$1,225,118,495	+$26,106,851	$0	$0	$36.62	154
2014 Q1	32,762,922	$1,104,788,693	+$9,047,120	$546,000	$270,000	$33.72	144